Log in

Login to your account

Username *
Password *
Remember Me

Multi Radiance Medical Logo

Call or Contact us today for more information: 1.440.542.0761 Refer a Friend
Vasomotor Rhinitis

Phototherapy for allergic rhinitis: a prospective, randomized, single-blind, placebo-controlled study

Cingi C, Cakli H, Yaz A, Songu M, Bal C.
Ther Adv Respir Dis. 2010 Aug;4(4):209-13. Epub 2010 Jun 29.

BACKGROUND: Phototherapy has a profound immunosuppressive effect, and phototherapeutic methods using both ultraviolet (UV) and visible light are therefore widely used for the therapy of various inflammatory skin diseases. It is also proposed that phototherapy, using a combination of UV-A (25%), UV-B (5%) and visible light (70%), may represent a therapeutic alternative in patients with allergic rhinitis.

METHOD: Seventy-nine patients were randomly assigned to receive either a combination of UV-A (25%), UV-B (5%) and visible light (70%), in the phototherapy group, or low-intensity visible light, in the control group. The efficacy of treatment was assessed by means of total nasal symptom score before treatment and 1 month after the end of treatment.

RESULTS: Total nasal scores decreased in both groups but the decrease was highly significant in the active treatment group when compared with the placebo (p < 0.001).

CONCLUSIONS: This study demonstrates that phototherapy may be an effective modality in the treatment of allergic rhinitis especially in cases of which commonly used drugs either are contraindicated and/or have insufficient efficacy.

Functional methods of study in the evaluation of the effectiveness of laser therapy of vasomotor rhinitis and some forms of prosopalgia

Shuster MA, Isaev VM, Kaevitser IM.
Vestn. Otorinolaringol. 1990 Sep-Oct;(5):21-7.

Highly sensitive instrumental methods such as rhinopneumography, rhinorheography, rheoencephalography and segmented sphygmography were used to measure the efficacy of contact laser therapy of the pterygopalatine ganglion to treat vasomotor rhinitis and trigeminal neuralgia. This method proved efficient in the case of the nervous form of vasomotor rhinitis, Sluder syndrome, and trigeminal neuralgia. Stable remission developed in 60% of patients.

Clinical effectiveness of magnetolaser therapy of vasomotor rhinitis

Mamedov AF.
Vestn Otorinolaringol. 1991 May-Jun;(3):60-3.

Magnet-laser therapy was used to treat vasomotor rhinitis in 90 patients. A constant magnet of 50 mT was applied to the exterior of the nose, and an infrared laser beam was applied via a light-guide to the reflexogenic zones of concha inferior. The radiation power density was 5 mW/cm2. The magnetic exposure time was 6-10 min and the laser exposure time was 3-5 min for each half of the nose. The therapeutic course was 8-12 sessions. The therapeutic results depended on the type of vasomotor rhinitis, clinical disorders, and duration of the disease. Good results were seen in 84 (93.3%) patients out of 90 cases. Stable remission was recorded in 61.1% patients, significant improvement of clinical manifestations of vasomotor rhinitis was observed in 32.2% cases. Best results were reported in patients with autonomic forms of vasomotor rhinitis who suffered from short-term disease and vasodilation disorders.

Request a Demo
Name (*)

Invalid Input
Email (*)

Invalid Input
Phone

Invalid Input



Upcoming Events

No events

Newsletter

Subscribe to our newsletter below and keep up with our latest news and events

This website contains information that has not been reviewed or approved by the FDA. Some of the claims and representations of the products contained on this site are cleared by regional regulatory bodies such as CE and Health Canada and may differ from those that are FDA 510K cleared.
What does this mean?